ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1056

Evolution of Health Care Consumption in the Knee and Hip Osteoarthritis Long Term Assessment Cohort, a French Population Based Cohort of Symptomatic Knee and/or Hip OA Patients

Anne-Christine Rat1,2,3, Jean-Hugues Salmon4, Willy Ngueyon Sime5, Maud Wieczorek6, Alain Saraux7, Claudine Gard8, Francis Guillemin9 and Bruno Fautrel10, 1Inserm, CIC-1433 Epidémiologie Clinique, Vandoeuvre-lès-Nancy, France, 2Rheumatology Department, CHRU Nancy, Vandoeuvre-lès-Nancy, France, 3Université de Lorraine, EA4360, APEMAC, Nancy, France, 4Rheumatology, Rheumatology Department CHU Teaching Hospital Reims, Reims, France, 5CIC 1433 Epidémiologie clinique, Inserm, Nancy, France, 6Université de Lorraine EA 4360 APEMAC, Nancy, France, 7Rheumatology Department, Rheumatology Department, CHU de la Cavale Blanche, Brest, France, Brest Cedex, France, 8Pitié Salpetrière hospital, Paris, France, 9CHRU Nancy, Clinical Epidemiology and Evaluation, Université de Lorraine, Paris Descartes University, APEMAC, EA 4360, Nancy, France, 10UPMC University Paris 06, Pitié-Salpétrière Hospital, Paris, France

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Hip, Knee and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Health Services Research Poster II: Osteoarthritis and Rheumatoid Arthritis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

–      Background/Purpose:  in hip and knee OA, one of the leading causes of global disability, recent population-based data of health care practices and utilization are scarce. Describing trajectories of patients’ patterns of care and their predictive factors is important to adapt health care practices and guide interventions to optimize patients’ use of health care services. The aim of the study was to describe health care utilization trajectories and associated factors of a representative sample of patients with knee or hip symptomatic OA.

–      Methods: the KHOALA cohort is a French population-based multicenter cohort of 878 patients with symptomatic knee and/or hip OA, aged between 40 and 75 years old recruited between 2007 and 2009. Patients are followed annually by self-report questionnaires. Analyses used the data from the 5 first years of the follow up. We used Latent Class Growth Analyses (LCGA) to define homogeneous subgroups of trajectories based on the individual health care consumptions over time, and logistic regressions to explain the differences between the identified trajectories with baseline characteristics.

–      Results: Among the 878 patients, 609 (69%) were women, 222 (25%) have hip OA, 607 (69%) knee OA and 49 (6%) both hip and knee OA. Groll comorbidity index (0-18) was 3.1 (1.6). The most optimal and clinically relevant models retrieved by LCGA were two group models for consultations with the different health care professionals (primary care physician (PCP), rheumatologist, orthopedic surgeon, physiotherapist), hospitalizations, use of assisting devices and acid hyaluronic (AH) injections, and 3 group models for corticoids injections and use of complementary and alternative medicine (CAM). In multivariate analyses, increasing age was independently associated with the trajectory of high number of consultations with PCP and rheumatologist, and with a high use of corticoids injections or complementary medicine. Impaired mental health was associated with the groups of frequent consultations with PCP, rheumatologists and physiotherapists and with corticoid injections. Pain was only associated with increasing number of orthopedic surgeons consultations and high use of assisting devices. Impaired function abilities were only associated with frequent hospitalizations. Comorbidities are associated with PCP consultations and hospitalizations (frequent use).

–      Conclusion:  In multivariate analyses, mental health impairment is the only symptom associated with trajectories of frequent use of medical care while pain is only associated with orthopedic surgeon consultations.

 


Disclosure: A. C. Rat, None; J. H. Salmon, None; W. Ngueyon Sime, None; M. Wieczorek, None; A. Saraux, None; C. Gard, None; F. Guillemin, None; B. Fautrel, AbbVIe, Biogen, BMS, Celgene, Hospira, Janssen, Eli Lilly and Company, Novartis, Pfizer, Roche, SOBI Pharma, UCB, 5.

To cite this abstract in AMA style:

Rat AC, Salmon JH, Ngueyon Sime W, Wieczorek M, Saraux A, Gard C, Guillemin F, Fautrel B. Evolution of Health Care Consumption in the Knee and Hip Osteoarthritis Long Term Assessment Cohort, a French Population Based Cohort of Symptomatic Knee and/or Hip OA Patients [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/evolution-of-health-care-consumption-in-the-knee-and-hip-osteoarthritis-long-term-assessment-cohort-a-french-population-based-cohort-of-symptomatic-knee-andor-hip-oa-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evolution-of-health-care-consumption-in-the-knee-and-hip-osteoarthritis-long-term-assessment-cohort-a-french-population-based-cohort-of-symptomatic-knee-andor-hip-oa-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology